Hydrolysis of the mRNA cap plays a pivotal role in initiating and completing mRNA turnover. In nematodes, mRNA metabolism and cap-interacting proteins must deal with two populations of mRNAs, spliced leader trans-spliced mRNAs with a trimethylguanosine cap and non-trans-spliced mRNAs with a monomethylguanosine cap. We describe here the characterization of nematode Dcp1 and Dcp2 proteins. Dcp1 was inactive in vitro on both free cap and capped RNA and did not significantly enhance Dcp2 activity. Nematode Dcp2 is an RNA-decapping protein that does not bind cap and is not inhibited by cap analogs but is effectively inhibited by competing RNA irrespective of RNA sequence and cap. Nematode Dcp2 activity is influenced by both 5 end sequence and its context. The trans-spliced leader sequence on mRNAs reduces Dcp2 activity ϳ10-fold, suggesting that 5-to-3 turnover of trans-spliced RNAs may be regulated. Nematode Dcp2 decaps both m 7 GpppG-and m 2,2,7 GpppG-capped RNAs. Surprisingly, both budding yeast and human Dcp2 are also active on m 2,2,7 GpppG-capped RNAs. Overall, the data suggest that Dcp2 activity can be influenced by both sequence and context and that Dcp2 may contribute to gene regulation in multiple RNA pathways, including monomethyl-and trimethylguanosine-capped RNAs.
RNA turnover is an important part of mRNA metabolism and contributes to gene expression (7, 24, 41, 59, 60) . A number of pathways of eukaryotic mRNA decay have been described (1, 7, 41, 56, 59, 60) . Among these are two general pathways of mRNA turnover, 3Ј-to-5Ј and 5Ј-to-3Ј exonucleolytic decay. Specialized mRNA turnover pathways are also known and include nonsense-mediated decay, endonuclease cleavage, and nonstop decay. Enzymes that cleave the mRNA cap participate in all of these turnover pathways (7, 10, 16, 21, 41) .
In both general pathways of mRNA turnover (3Ј-to-5Ј and 5Ј-to-3Ј decay), decay is initiated by deadenylation or shortening of the mRNA poly(A) tail by deadenylases. In the 3Ј-to-5Ј pathway, deadenylation facilitates access of a complex of 3Ј-to-5Ј exonucleases, the exosome, to the 3Ј end of the RNA. The exosome degrades the RNA 3Ј to 5Ј until it reaches the RNA cap. The RNA cap consists of a guanine residue added cotranscriptionally to the first nucleotide of an mRNA transcript through an inverted 5Ј-5Ј triphosphate bridge. This unusual triphosphate linkage is not a substrate for general exo-or endonucleases. Consequently, complete 3Ј-to-5Ј exonucleolytic decay results in the RNA degraded to its constituent nucleotide monophosphates and the remaining dinucleotide, the mRNA cap. The remaining cap is a substrate for the DcpS scavenger decapping enzyme, which hydrolyzes the m 7 GpppN cap to m 7 Gp and ppN (6, 10, 20, 21, 31, 32, 40, 45, 54, 58) . In the 5Ј-to-3Ј pathway, deadenylation of the RNA triggers decapping of the RNA by the enzyme complex, Dcp1/Dcp2 (2, 7, 10, 14, 21, 23, 26, 41, 42, 49, 50, 53, 57) . Decapping of the deadenylated RNA by Dcp1/Dcp2 results in m 7 Gpp and p-RNA products. The 5Ј monophosphate RNA is a substrate for 5Ј-to-3Ј exonucleolytic decay by an exonuclease such as Xrn1. Thus, hydrolysis of the cap plays important roles in both initiating and completing mRNA decay in the two general mRNA turnover pathways. These decapping enzymes also participate in the specialized mRNA turnover pathways (18, 28, 34) .
Spliced leader (SL) RNA trans splicing generates the mature 5Ј ends of mRNAs by addition of a spliced leader sequence to the pre-mRNA (4, 11, 29, 38, 39) . This mechanism of gene expression is present in diverse eukaryotes including some flagellate protozoa, hydra, nematodes, rotifers, flatworms, and even primitive chordates (38, 43) . In metazoa, addition of the spliced leader sequence also adds an atypical cap to the RNA, a trimethylguanosine (TMG) cap (m 2,2,7 GpppN), compared to the typical m 7 GpppN eukaryotic cap (30, 37, 52, 55) . However, not all cellular mRNAs in trans-splicing metazoa undergo spliced leader addition. Therefore, two populations of mRNA are present in the cell, non-trans-spliced mRNAs with the typical m 7 GpppN cap and variable 5Ј untranslated region sequence and trans-spliced mRNAs with the 5Ј spliced leader sequence and an m 2,2,7 GpppN cap. mRNA metabolism and cap-interacting proteins must deal with these two distinctly capped mRNA populations. One of the interests of our laboratory is to understand the posttranscriptional role of spliced leader trans splicing on mRNA metabolism and to understand how mRNA metabolism and cap-interacting proteins have ac-commodated these two RNA populations. To address these questions, we have chosen to use two nematodes as model systems, Caenorhabditis elegans and Ascaris. Using Ascaris embryos, we have developed both in vitro translation and decay systems as well as biolistic methods to evaluate the role of the spliced leader sequence and TMG cap on mRNA translation and decay (6, 12, 27) . Using the in vitro decay system, we recently demonstrated that the predominant general pathway of mRNA decay is 3Ј-to-5Ј exonucleolytic decay followed by "scavenger" hydrolysis of the resulting mRNA cap (6) . 5Ј-to-3Ј decay also occurs in the Ascaris extracts but is ϳ15-fold less active than the 3Ј-to-5Ј decay pathway. Both pathways in vitro are capable of hydrolysis of both the m 7 GpppN cap and the m 2,2,7 GpppN cap derived from the spliced leader. We have also shown that the recombinant C. elegans "scavenger" enzyme DcpS can hydrolyze both the m 7 GpppN and m 2,2,7 GpppN caps. In contrast, human DcpS is not capable of hydrolyzing m 2,2,7 GpppN caps, and the C. elegans enzyme substrate requirements differ from those of the human enzyme (6) .
To extend these studies on mRNA turnover and decapping in nematodes, we have now cloned, expressed, and analyzed recombinant C. elegans Dcp1 and Dcp2. Nematode Dcp2 requires an RNA substrate of at least 50 nucleotides (nt), is an RNA binding protein, does not directly bind the RNA cap, and is competitively inhibited by RNA irrespective of sequence and cap. Nematode Dcp2 can also hydrolyze m 2,2,7 GpppG caps. This is a general property of eukaryotic Dcp2, since we also demonstrate that budding yeast and human Dcp2 can also hydrolyze m 2,2,7 GpppG caps. In addition, nematode Dcp2 activity is affected by both the 5Ј terminal sequence and the context. Overall, these data suggest that Dcp2 could be involved in both mRNA and snRNA or snoRNA turnover, that the Dcp2 activity is affected by RNA sequence, and that these properties have implications for RNA turnover and its regulation.
MATERIALS AND METHODS
Cloning. Total C. elegans RNA was isolated from mixed-stage C. elegans cultures using Trizol (Invitrogen, Carlsbad, CA). First-strand cDNA was generated using SuperScript II reverse transcriptase and oligo(dT) primers (Invitrogen). The C. elegans Dcp1 and Dcp2 open reading frames were amplified from the cDNA using specific primers (see Fig. S4 in the supplemental material) and either Expand high-fidelity polymerase (Roche, Indianapolis, IN) or Taq DNA polymerase (Promega, Madison, WI). The Dcp1 coding region PCR product was cloned into pET16b (Novagen, Madison, WI) as an NdeI and BamHI fragment or the yeast vector pESP-1 (Stratagene, La Jolla, CA) as a BamHI fragment using Escherichia coli DH5␣ as a host. The Dcp2 coding-region PCR products were digested with BamHI and EcoRI (Dcp2⌬BoxB and Dcp2 1-659) or BamHI and NotI (full-length Dcp2) and cloned into pET32a (Novagen, Madison, WI) using DH5␣ as a host. Recombinants were identified and confirmed by DNA sequencing. Dcp2 1-479 was subcloned from the full-length Dcp2 as a BamHI and EcoRV fragment into the BamHI and Hind III (blunted) sites of pET32a. The single Dcp2 mutants I259T and I295T were Taq DNA polymerase mutants identified during sequencing of clones derived from the original cDNA PCR. Additional clones of Dcp2 were generated either by direct subcloning or PCR cloning into pET32a. Clones were then transformed into Rosetta DE3 (Novagen) for protein expression. The single E275Q mutation in the nudix motif of Dcp2 1-479 was generated using the QuikChange II site-directed mutagenesis kit (Stratagene, La Jolla, CA).
Recombinant protein expression and purification. Yeast expression and glutathione S-transferase purification of Dcp1 in pESP-1 was carried out as described by the manufacturer (Stratagene). Bacterial protein expression was induced with 0.4 mM isopropyl ␤-D-thiogalactoside for 3 h at 30°C in cultures previously grown at 37°C to an optical density at 600 nm of 0.6. Frozen bacterial pellets were resuspended in ice-cold lysis buffer (50 mM Na 2 HPO 4 , pH 7.5, 600 mM NaCl, 600 mM urea, 10% glycerol, 1% Triton X-100), lysozyme was added to a final concentration of 1 mg/ml, and the suspension was incubated on ice for 30 min and then sonicated. His-tagged Dcp2 was bound to Ni 2ϩ -nitrilotriacetic acid (NTA)-agarose (QIAGEN Inc., Valencia, CA) for 60 min at 4°C, unbound proteins removed with washing buffer (50 mM Na 2 HPO 4 , pH 7.5, 600 mM NaCl), and the bound proteins eluted with wash buffer containing increasing concentrations of imidazole (20 to 300 mM imidazole). Fractions containing Dcp1 or Dcp2 were dialyzed against 20 mM Tris, pH 7.5, 50 mM KCl, 20% glycerol, 1 mM dithiothreitol (DTT), and 0.5 mM phenylmethylsulfonyl fluoride and stored at Ϫ80°C. Dcp2 was further purified following dialysis into 50 mM Na 2 HPO 4 (pH 8.0) and 150 mM NaCl on a HiTrap heparin column using a gradient from 0.15 to 1 M NaCl in 50 mM Na 2 HPO 4 (pH 8.0) (Pharmacia, Piscataway, NJ). The most-pure Dcp2 fractions with activity were dialyzed against 20 mM Tris, pH 7.5, 50 mM KCl, 20% glycerol, 1 mM DTT, and 0.5 mM phenylmethylsulfonyl fluoride and stored at Ϫ80°C. Human Dcp2 was expressed and purified as described previously (23) . Budding yeast Dcp1 and Dcp2 (generously provided by Carolyn Decker and Roy Parker) were coexpressed and purified as described previously (47) .
Substrate preparation. Preparation of PCR templates for in vitro transcription and transcription reactions was carried out as previously described (6) . Caplabeled RNAs were prepared from uncapped RNA substrates using [␣-
32 P]GTP (Perkin-Elmer, Boston, MA) and recombinant vaccinia RNA guanylyltransferase and (guanine-N 7 )-methyltransferase (generously provided by Stewart Shuman), human capping enzyme (generously provided by Aaron Shatkin), and cap-specific 2Ј-O-methyltransferase (generously provided by Paul Gershon) as described previously (6) . Cap-labeled RNAs were typically gel purified by denaturing polyacrylamide gel electrophoresis (PAGE) prior to use or passed several times over Sephadex G-50. m 3 2,2,7 Gp*ppG m -SL snRNA was produced by hypermethylation of an m 7 Gp*ppG m -SL snRNA in Ascaris whole-cell embryo translation extracts followed by phenol-chloroform extraction and ethanol precipitation or gel purification as described previously (6) . Enrichment for the hypermethylated SL RNA was carried out by immunoprecipitation with anti-TMG antibodies (5) using conditions recommended by the supplier (Synaptic Systems, Gottingen, Germany). Cap-labeled dinucleoside triphosphates were prepared by nuclease P1 digestion as described previously (6) .
Decapping reactions. Decapping reactions were carried out as previously described (6) 32 P cap-labeled dinucleotides were carried out as described previously (6) . Reactions were stopped either by addition of 50 mM EDTA or by freezing at Ϫ80°C. Reaction products were resolved by thin-layer chromatography (TLC) and 25% PAGE-5 M urea and subjected to autoradiography as described previously (6) .
Substrate and product characterization. Cap-labeled RNA substrates, the RNA cap, and decapping products were characterized using a variety of methods including comigration with known standards using TLC or denaturing PAGE analysis and several enzyme shift strategies as described previously (6) . TLC was carried out using polyethyleneimine (PEI)-cellulose as the stationary phase and ammonium sulfate (0.45 M) or lithium chloride (0.3 to 1 M) as the mobile phase. PAGE analysis was done using 5 M urea 20% or 25% denaturing gels as described previously (3, 6) . Reaction substrates and products were then quantified by phosphorimager analysis of the TLC or PAGE separations using Molecular Dynamics STORM 860 and ImageQuant software. Dinucleoside cap analogues and methylated nucleotides used as standards or competitors were prepared as described previously (6) and were generously provided by Edward Darzynkiewicz.
Nucleotide sequence accession number. The C. elegans Dcp2 mRNA sequence has been deposited in GenBank under accession no. DQ143943. larly in the amino-terminal ϳ150 amino acids. An annotated Dcp2 ortholog was also identified in the C. elegans database (ndx-5), predicted to encode either 367-or 344-amino-acid proteins (CE23761 and CE17847) that differ in their amino termini as a function of alternative 5Ј exon use. Sequence alignment of these proteins with other Dcp2 orthologs indicated that these predicted proteins lacked a conserved carboxy-terminal domain present in other Dcp2 proteins, the Box B domain, as well as a portion of the nudix fold (see Fig. 1A , Dcp2⌬BoxB). Our bioinformatic reevaluation of the genomic region encoding C. elegans Dcp2 identified a 5Ј splice site within several amino acids of the database's predicted ndx-5 carboxy terminus that could lead to inclusion of additional 3Ј exons.
To experimentally determine the organization of the expressed open reading frame(s) from the putative Dcp2 locus, PCR primer pairs were designed to test several of our revised coding region predictions. Reverse transcription (RT)-PCR and sequence analysis confirmed the expression of C. elegans RNAs encoding the database-predicted 367-and 344-aminoacid ndx-5 proteins that lack the conserved Box B domain ( . elegans database open reading frame, CE18392. The fused 3Ј CE18392 coding region has no significant similarity with characterized proteins. Notably, the C. briggsae gene and mRNA annotation for this locus support the longer proteinencoding transcript we predicted and identified (see Fig. S2 in the supplemental material). In addition, antibodies raised against C. elegans Dcp2 recognize a protein in C. elegans extracts of the predicted size for the 770-amino-acid protein (molecular weight, ϳ85,000).
Cloning, expression, and purification of Dcp1 and Dcp2. The predicted C. elegans Dcp1 332-amino-acid coding region was amplified by RT-PCR from mixed-stage C. elegans cDNA and cloned into the bacterial expression vector pET16b and into the yeast expression vector pESP-1. Recombinant proteins derived from the two hosts were purified by Ni 2ϩ -NTA agarose chromatography and GST-affinity or anti-Flag chromatography, respectively. C. elegans Dcp2 proteins lacking Box B (Dcp2⌬ BoxB) and the full 770-amino-acid open reading frame were amplified by RT-PCR from mixed-stage C. elegans cDNA and cloned into pET32a, and the bacterially expressed recombinant proteins were purified by Ni 2ϩ -NTA agarose chromatography.
To determine if the recombinant Dcp1 or Dcp2 proteins were functional decapping enzymes, decapping assays were carried out using purified Dcp1 and Dcp2 proteins. The de- capping assay determines whether a protein is able to hydrolyze the cap of a 250-nucleotide cap-labeled m 7 Gp*ppG RNA. As shown in Fig. 2A (lane 3) , protein derived from the long Dcp2 open reading frame had significant decapping activity, producing a decapping product that comigrated on TLC analysis with m 7 Gp*p, the nucleoside diphosphate product characteristic of Dcp1/Dcp2-type decapping enzymes. The decapping product was independently confirmed to be m 7 Gp*p based on comigration of the product with standards using independent TLC solvent separations, 25% PAGE analysis, and demonstration of the conversion of the nucleoside diphosphate product to its corresponding nucleoside triphosphate with nucleoside diphosphate kinase ( Fig. 2B and C) . In contrast, recombinant C. elegans Dcp1 protein purified from either bacteria (see Fig. 1B, lane 2) or yeast showed no decapping activity under a variety of assay conditions including reaction buffers with Mn 2ϩ (Fig. 2A, lanes 7 and 8) . The nematode Dcp2 protein lacking a portion of the nudix fold and Dcp2 Box B (Dcp2⌬ BoxB) (see Fig. 1B , lane 3) was inactive in decapping ( Fig. 2A , lanes 5 and 6). Consistent with the essential nature of the Box B regions, the N-terminal fragment of Dcp2 (1-479) that includes Box B was as active as the full-length protein ( Fig. 2A) . Single point mutations in Dcp2 1-479 within the nudix motif (I259T or E275Q) lead to almost complete loss of decapping activity, whereas the single mutation I295T leads only to reduced activity ( Fig. 2D and data not shown) . Overall, these data indicate that the RNA decapping we observe is derived from expression of the C. elegans Dcp2 protein. For the majority of the experiments described below, the enzyme activity illustrated is derived from the Dcp2 protein (1-479) expressed and purified as a fusion protein from pET32a by Ni 2ϩ -NTA agarose and then heparin chromatography (Fig. 1B,  lane 4) . Dcp1 activity. Dcp2 was originally identified as an enhancer of Dcp1 decapping activity (14) . More recently it has been shown that Dcp2 is the catalytic subunit of the Dcp1/Dcp2 complex (31, 33, 53) and that in budding yeast Dcp1 can enhance the decapping activity of Dcp2 (47, 49) . In addition, the decapping activity of the yeast or human proteins was reported to be significantly higher in the presence of the Mn 2ϩ ion (42, 49) . Our initial assays for decapping activity of Dcp1 and Dcp2 were conducted with Mg 2ϩ as the sole cation. We reevaluated Dcp1 activity in the presence of both the Mg 2ϩ ion and the Mn 2ϩ ion and also examined the effect of Dcp1 on Dcp2 activity. As illustrated in Fig. 2A (lanes 7 to 9) , Dcp1 was also inactive for decapping in the presence or absence of the Mn 2ϩ ion and had only a small effect on the decapping activity of Dcp2. Furthermore, Dcp1 was shown to be inactive on several different test RNA substrates (different RNA sequences and different caps including GpppG-, m 7 GpppG m -, and m 2,2,7 GpppG m -RNA) and also had no decapping activity directly on dinucleotide caps (GpppG, m 7 GpppG m , and m 2,2,7 GpppG m cap) (data not shown). We also tested whether the addition of Dcp1 to Dcp2 differentially enhanced the decapping of different RNA substrates and different cap structures (e.g., test RNAs with or without SL, SL RNA, and U1 RNA with GpppG, m 7 GpppG, and hypermethylated caps). Enhancement of nematode Dcp2 decapping on different caps or RNA substrates with the addition of Dcp1 was limited (observed less than twofold) and in most cases did not enhance Dcp2 activity (data not shown). Although Dcp1 was purified using the same conditions and simultaneously with Dcp2, it remains possible that bacterially expressed nematode Dcp1 may not be functional.
Substrate length specificity of C. elegans Dcp2. Decapping proteins differ in their substrate length requirements as a function of both the type of decapping enzyme and the organism source. We therefore examined the substrate length requirement of nematode Dcp2. Dcp2 was not capable of hydrolyzing the dinucleotide cap m 7 GpppG lacking an RNA (Fig. 3A, lane  2) or other dinucleotide caps (GpppG, m 7 GpppG m , and m 2,2,7 GpppG m ) (data not shown). These dinucleotide cap substrates are readily cleaved by nematode DcpS (Fig. 3A, lane 1) (6). Dcp2 exhibited minimal activity on m 7 GpppG cap-labeled Renilla substrate up to ϳ25 nucleotides (5, 10, 20 , and 25 nucleotide substrates tested) (data not shown). Optimal activity was observed with a ϳ250-nucleotide Renilla substrate (Fig.  3B) . However, using a second series of RNA substrates derived from the pGEM-7Zf polylinker, a small amount of Dcp2 activity was observed on a 31-nucleotide substrate and optimal activity was observed on capped substrates greater than 50 nucleotides (Fig. 3C) . Therefore, minimal substrate length demonstrated some variation with the two substrates examined. This indicates that optimal activity on a substrate is likely a function of length as well as sequence and/or structure.
Consistent with a requirement for the RNA moiety attached to the cap, Dcp2 activity is not competitively inhibited by dinucleotide cap or methylated nucleotides added to reactions, as illustrated in the TLC and PAGE assays in Fig. 4A . In addition, Dcp2 does not bind to cap based on m 7 GTP-Sepharose affinity chromatography assays (data not shown). However, addition of capped or uncapped RNA as a competitor to Dcp2 decapping reactions effectively inhibited Dcp2 activity ( Fig. 4B and 5B).
RNA sequence and Dcp2 activity. Approximately 70% of nematode mRNAs undergo maturation through trans splicing (27, 36, 61) . This processing event forms the mature 5Ј ends of mRNA by addition of a conserved 22-nucleotide sequence known as the spliced leader. To determine whether this sequence had any effect on C. elegans Dcp2 decapping in vitro, we compared Dcp2 activity on cap-labeled RNA that differed only by substitution of the first 22 nucleotides with the nematode SL1 sequence (GGUUUAAUUACCCAAGUUUGAG). Dcp2 decapping activity was reduced ϳ10-fold on an RNA substrate with a 5Ј terminal SL sequence (Fig. 5, compare lanes  1 and 2) . This effect was also observed when a second C. elegans spliced leader (SL2, GGUUUUAACCCAGUUACU CAAG) that is 45% identical to SL1 (Fig. 5, compare lanes 1  and 3) was substituted for the 5Ј end sequence of the Renilla RNA test substrate. Addition of the complete 5Ј untranslated region (33 nt) of an SL1 trans-spliced mRNA (SL-12) to the test substrate also significantly reduced decapping activity (Fig.  5A, lane 4) . Similar results were also observed with the 5Ј 250 nucleotides of a native trans-spliced mRNA (lane 5). However, several control RNAs (e.g., actin and elongation factor) lacking an SL and the test Renilla RNA with either random nucleotides at the 5Ј end or a 3Ј 50-nucleotide poly(A) tail were efficiently decapped (lanes 6 to 7 and 11; also data not shown). At present it is not clear whether the sequence or a structural component of the SL is responsible for the decrease in decap-
ping. However, M-Fold RNA analysis failed to detect a stable structure or extensive base pairing within the SL or between the SL and the 3Ј RNA substrate. These data suggest that either the sequence or structure of the SL at the 5Ј end of an RNA leads to a reduction in decapping. We also tested two other small RNA substrates, the SL RNA and U1 RNA. The 108-nucleotide spliced leader RNA is the substrate utilized for the trans-splicing reaction. The first 22 nucleotides of this RNA are trans spliced to a pre-mRNA to form the 5Ј end of a trans-spliced mRNA. Interestingly, the SL sequence at the 5Ј end of SL RNA was cleaved with relatively high efficiency in comparison to other test RNAs with the same SL sequence at their 5Ј ends (Fig. 5A, compare lanes 1, 2, and  9 ). This was unexpected, since the SL RNA substrate is predicted to have the spliced leader sequence in a relatively stable 5Ј stem-loop structure (consisting of the first 30 nucleotides) including base pairing of the first two nucleotides (13) . These attributes led us to predict that the SL RNA would be a poor Dcp2 substrate. However, the SL RNA is readily decapped in the assays. A second and somewhat larger small nuclear RNA (U1) whose 5Ј end is predicted to not be base paired (the 5Ј end of U1 is free to base pair with the 5Ј spliced site in cis splicing) was also tested as a decapping substrate. In spite of the longer length (170 nt) and predicted absence of 5Ј-end base pairing or a stem-loop immediately adjacent to the cap, the U1 RNA was a relatively poor substrate for Dcp2 (Fig. 5A , compare lanes 1, 9, and 10). Overall, these data indicate that the decapping rate of different cellular RNAs is likely to vary.
Ten-to 25-fold molar excess cold competitor RNA added to a decapping reaction is an effective competitor and inhibits Dcp2 activity (Fig. 4B and 5B). However, neither the RNA sequence, type of cap, nor addition of the SL sequence to the RNA has a large effect in these competition experiments (Fig.  5B and data not shown) . One interpretation of these data is that Dcp2 contains a general and independent RNA binding domain. Following RNA binding, subsequent nucleotide interactions and access to the cap within the cap-binding/cleavage pocket can influence catalysis.
Cap specificity for nematode decapping. Addition of the spliced leader during trans splicing also brings a different cap to the 5Ј ends of trans-spliced mRNAs, a trimethylguanosine cap (m 2,2,7 GpppN) compared to the typical m 7 7 Gp*ppG dinucleotide cap prepared as described previously (6) was used as a substrate for Dcp1, Dcp2, DcpS, and Dcp1/2 decapping. The reaction products were resolved using PEI-cellulose TLC and 0.45 M ammonium sulfate followed by autoradiography. No decapping products were observed following incubation of Dcp1 or Dcp2 with the substrate. The arrows illustrate the location of the input m 7 Gp*ppG substrate and the only products observed from the reactions, the m 7 Gp* derived from DcpS complete hydrolysis of the substrate. The ␤-gal lane represents a decapping assay carried out with a similarly purified recombinant ␤-galactosidase protein. (B) RNA length and substrate dependence of C. elegans Dcp2 on a Renilla RNA. m 7 Gp*pppG-capped Renilla RNAs of increasing length were evaluated as substrates for C. elegans Dcp2. In addition to the RNAs illustrated, Renilla RNAs of 5, 10, 20, and 25 nucleotides were also examined and were poor substrates for Dcp2 (data not shown). The percent conversion of the input RNA substrate to m 7 Gp*p is illustrated (% Decapping), determined as described in the legend to Fig. 2 . Zero length represents dinucleotide cap, m 7 Gp*ppG, which as illustrated is not hydrolyzed by Dcp2. (C) RNA length and substrate dependence of C. elegans Dcp2 on pGEM-7Zf polylinker-derived RNAs. m 7 Gp*ppG-capped RNAs of increasing length derived from the pGEM-7ZF polylinker were evaluated as substrates for C. elegans Dcp2. Note that for this substrate in comparison with the Renilla RNA (see B above), decapping activity becomes optimal on RNA as small as ϳ50 nucleotides.
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and other substrates (see below) and analysis of their RNA caps is provided in Fig. S3 in the supplemental material.
To produce cap-labeled trimethylguanosine substrates, m 7 GpppG m -capped SL RNA was incubated in Ascaris embryo whole-cell translation extracts (6, 37) . Following this treatment, the RNA was intact (Fig. 6A, lanes 1 to 4) , and ϳ70% of the m 7 GpppG m -capped SL RNA was trimethylated (m 2,2,7 GpppG m -SL RNA), as deduced by nuclease P1 characterization of the resulting RNA cap structure (Fig. 6A, lane 5) . To further enrich for TMG cap-labeled RNA, the RNA was immunoprecipitated using anti-TMG antibodies. Immunoprecipitation of the SL RNA produced SL RNA preparations that were typically 95% m 2,2,7 GpppG m -SL RNA based on P1 nuclease digestions and TLC analysis of the RNA cap (Fig. 6A,  lane 6) . m 7 GpppG-capped RNAs are readily cleaved by nematode Dcp2. In higher eukaryotes, the RNA cap typically includes methyl groups on the 2Ј-ribose of the first and second encoded bases, cap 1 and cap 2, respectively. Addition of a 2Ј-O-ribose methyl group on the first encoded base did not have a significant effect on nematode Dcp2 activity (Fig. 5A, compare lanes  1 and 8) . However, the presence of an N-7 methyl group is an important determinant for nematode decapping, since its absence leads to a significant reduction of decapping activity (evidenced by production of only small amounts of Gp*p product derived from Gp*ppG-capped RNA) (Fig. 5A , compare lanes 1 and 12; Fig. 6B , compare lanes 7 and 10). m 2,2,7 GpppG m on the SL RNA (and U1 RNA; data not shown) is also decapped, producing m 2,2,7 Gp*p (Fig. 6B, lanes 8 and  9) . The diphosphate products produced by Dcp2 decapping of GpppG, m 7 GpppG-, m 7 GpppG m , and m 2,2,7 GpppG m RNAs were further characterized by comigration with markers on Reaction products from the competition assays were resolved using both a TLC and PAGE assay. Note that these cap analogs (ϩ m 7 GpppG, ϩ m 7 GDP, or ϩ m 7 GTP) do not inhibit the decapping reactions (i.e., levels of m 7 GDP produced). (B) RNA is a competitor of Dcp2 activity. Dcp2 activity (50 ng of protein) on a 250-nucleotide m 7 Gp*pppG-capped Renilla RNA was evaluated in the absence and presence of increasing amounts of the same cold RNA. Two nanograms of labeled RNA was present in the reaction. Cold RNA competitor was thus present at equal, 10-fold, or 100-fold excess. Note that addition of competing RNA to the decapping reaction effectively inhibits Dcp2 decapping. Similar results were obtained using the Renilla RNA substrate and a nonhomologous firefly luciferase RNA as competitor RNA (data not shown).
VOL. 25, 2005 Dcp2 DECAPS m 2,2,7 GpppN-CAPPED RNAs 8785 PAGE analysis (Fig. 6C, lanes 11 to 14) and the ability to convert the diphosphate products to triphosphates with nucleoside diphosphate kinase treatment (data not shown). These analyses confirm that the primary products derived from all these cap substrates are the diphosphates of their capped RNA substrates. Therefore, nematode Dcp2 cleaves m 7 GpppG-, m 7 GpppG m -, and m 2,2,7 GpppG m -capped RNAs. GpppGcapped RNAs are also cleaved, but at a much-reduced efficiency (Fig. 6B, compare lanes 7 and 10) . Importantly, the mutation in the nudix motif (E275Q) of nematode Dcp2 also abolishes most of the m 2,2,7 GpppG m decapping activity (Fig.  6D) GpppG caps, whereas their mammalian counterparts cannot (6, 27) . In a comparative study we determined the abilities of human and yeast Dcp2 enzymes to hydrolyze m 2,2,7 GpppG-capped RNA. Unexpectedly, incubation of human Dcp2 with m 2,2,7 GpppG-capped RNA resulted in the hydrolysis of the TMG cap-containing RNA, producing m 2,2,7 Gpp, as illustrated by-product migration in TLC analysis (Fig. 7A) . The identity of the diphosphate FIG. 5 . C. elegans Dcp2 activity is sequence and context dependent. (A) Sequence and context dependence of C. elegans Dcp2 activity. The illustrated RNAs were cap labeled, and equivalent amounts of RNA were used as substrates for C. elegans Dcp2 (50 ng of protein). Reactions were carried out in the linear range of both protein and RNA concentration. All RNAs are ϳ250 nucleotides in length except for the SL RNA (108 nt), U1 RNA (170 nt), and TriEx RNA (1,900 nt). Reaction products were resolved on PEI-cellulose TLC with 0.45 M ammonium sulfate and visualized by autoradiography. Percent decapping of the substrate was determined as described in the legend to Fig. 2A. (B) RNA competition is independent of cap and SL sequence. Five nanograms of m 7 Gp*ppG cap-labeled 250-nucleotide Renilla RNA was incubated with 50 ng of Dcp2 protein in the presence or absence of 100 ng of the illustrated competitor RNAs. The competition assay was carried out in the linear range of both the assay and competitor RNA. RNA competition is generally equivalent regardless of the cap or presence of the SL sequence. Similar results were obtained using the Renilla RNA as the test substrate and a nonhomologous firefly luciferase RNA as the competitor RNA (data not shown).
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product was further confirmed by its conversion to its corresponding triphosphate with NDPK (Fig. 7B) . In addition, budding yeast Dcp1/Dcp2 was also able to cleave m 2,2,7 GpppGcapped RNA, producing m 2,2,7 Gpp (Fig. 7C) . These data indicate that the ability to cleave m 2,2,7 GpppG-capped RNA is phylogenetically conserved in diverse Dcp2 proteins. The human enzyme cleaves m 7 GpppG m -and m 2,2,7 GpppG m -capped RNA with equivalent efficiencies, whereas the yeast enzyme is ϳ30% less efficient on m 2,2,7 GpppG m -capped RNA. snRNAs and some snoRNAs have trimethylguanosine caps. Thus, in addition to its function in decapping cellular mRNAs, Dcp2 may also function in decapping and the turnover of snRNAs and some snoRNAs.
DISCUSSION
We have shown that nematode Dcp2 is an RNA-decapping enzyme and functions in the absence of C. elegans Dcp1. The optimal substrate length of C. elegans Dcp2 is ϳ50 nucleotides or greater, but this length requirement may also be substrate dependent. C. elegans Dcp2 does not directly bind to cap and is not inhibited by cap or cap analogs. RNA, however, is an effective competitive inhibitor of Dcp2 activity. Nematode Dcp2 is therefore similar in several respects to human and yeast Dcp2 (42, 49) . The effect of RNA competition on nematode Dcp2 activity is not significantly affected by the RNA sequence, cap, or addition of the spliced leader sequence. However, the 5Ј terminal sequence of the RNA substrate can influence decapping activity. These data indicate that nematode Dcp2 is a general RNA binding protein, that initial RNA binding is independent of the cap, and that decapping activity can be influenced by 5Ј terminal sequence.
Influence of the SL sequence on decapping. Addition of a nematode spliced leader sequence to the 5Ј end of a test RNA leads to an ϳ10-fold reduction in Dcp2 decapping. The reduction in Dcp2 activity appears context dependent, since the spliced leader on the SL RNA is a relatively good substrate for decapping. Competing RNA with the SL sequence did not show any increased effectiveness as a competitor. These data suggest that C. elegans Dcp2 first binds RNA (perhaps in a nonspecific manner), and subsequent decapping can be influenced by the context of the RNA elements near the 5Ј end of the RNA. This view suggests the protein has at least two independent domains, one for RNA binding and the second for cap cleavage. The catalytic activity of the latter domain can be influenced by both sequence and context. Steiger et al. found that annealing a DNA oligonucleotide to the 5Ј end of an RNA leading to an RNA/DNA duplex within the first 25 nt reduced yeast decapping by ϳ5-fold (17, 49) . These data suggest that sequestering the 5Ј end of the RNA can inhibit decapping. Yeast Dhhp1, an RNA helicase, has also been shown to be an enhancer of yeast decapping (8, 17) , supporting the idea that access to the cap or 5Ј end of the RNA can be an important determinant in decapping. Our data provide the first evidence that a specific sequence and its context at the 5Ј end of an RNA can influence decapping.
Reduced decapping of mRNAs with a spliced leader se- quence has implications for nematode mRNA metabolism. Since 70% of the mRNAs in C. elegans and Ascaris have a spliced leader sequence (27, 36, 61) , trans-spliced mRNAs might typically be subject to limited 5Ј-to-3Ј decay due to reduced decapping of the SL mRNAs. Our in vitro decay data in Ascaris whole-cell embryo extracts indicate that the 3Ј-to-5Ј decay pathway is at least 15 times more active than the 5Ј-to-3Ј decay pathway (6). Dcp2 decapping followed by 5Ј-to-3Ј decay might be a more highly regulated pathway. Under this scenario, Dcp2 decapping of SL-containing mRNAs might be limited but could be influenced and regulated by trans-interacting proteins. Several decapping enhancing proteins have been identified and characterized in yeast (8, 15, 17, 25, 46) . The presence of the SL sequence at the 5Ј end of an RNA appears to have differential effects on Dcp2 decapping. When present on the SL RNA, decapping does not appear significantly limited in spite of the known secondary structure of the SL RNA. These data suggest that both sequence and context are important determinants for decapping. Therefore, individual trans-spliced mRNAs could contain additional sequence elements that can influence decapping. Notably, both in vitro and in vivo we do not see significant differences in the mRNA half-lives of test transcripts comparing a test RNA with or without a spliced leader and with a trimethylguanosine cap (27) (L. S. Cohen et al., submitted for publication). This further suggests that under the conditions of the experiments, 3Ј-to-5Ј decay may be predominant, and that our test RNA does not contain sequences that facilitate enhanced decapping in the presence of the SL.
We have also observed a reduction of decapping efficiency on the nematode U1 RNA. The 5Ј-terminal 12 nucleotides of the RNA are predicted to not be base paired (this is a phylogenetically conserved property of U1 RNAs) and are thus not a likely explanation for reduced decapping on this substrate. Reduced decapping of U1 RNA could be due to sequence or structural elements that effect either initial RNA binding or catalysis or both. One possibility is that Dcp2 requires more than 12 unpaired nucleotides for access to or catalysis of the cap. Both U1 and the SL RNA are predicted to form significant secondary structures during the decapping incubation period. Little is known regarding the tertiary structure of these RNAs that might influence decapping.
Dcp2 is a TMG-decapping enzyme. Nematode Dcp2 has limited activity on GpppG-capped RNA substrates. Dcp2 activity is significantly greater on m 7 GpppG-capped RNA, indicating that the N-7 methyl group is an important determinant for decapping activity. Similar observations have been made for both the budding yeast and human enzymes (26, 53, 57) . C. elegans Dcp2 does not appear to be significantly influenced by a 2Ј-O-methyl (cap 1). This is consistent with the presence of at least a cap 1 in higher eukaryotes. Budding yeast, however, are thought to not have a cap 1 (35, 48) . Yeast Dcp2 is also capable of hydrolyzing m 7 GpppG m -capped RNA (data not shown). This suggests that at least 2Ј-O-methyl ribose residues are not likely to influence decapping.
Nematode Dcp2 is also equally active in the hydrolysis of m 2,2,7 GpppG m -capped RNA. Given that a large percentage of nematode mRNAs have a trimethylguanosine cap, we predicted that the nematode enzyme was likely to be functional on this cap structure. We have observed that other cap-interacting proteins in nematodes (DcpS and eIF4E) are capable of interacting with both m 7 GpppG and m 2,2,7 GpppG caps (6, 27) . In contrast, the human orthologs of these proteins have limited affinity and activity on m 2,2,7 GpppG caps, suggesting that the nematode enzymes have evolved to accommodate mRNAs with m 2,2,7 GpppG caps. Unexpectedly, we observed that both the human and budding yeast Dcp2 are very efficient in hydrolyzing m 2,2,7 GpppG-capped RNA. Cleavage of m 2,2,7 GpppGcapped RNA is thus a phylogenetically conserved property of Dcp2 proteins. Furthermore, since snRNA and some snoRNAs have hypermethylated caps, Dcp2 proteins may be involved in the decapping and turnover of sn-and snoRNAs.
Notably, Dcp2 activity is also substrate dependent, as illustrated by the much lower efficiency of decapping U1 snRNA than that for the SL RNA. Whether the greater activity on the SL RNA in vitro is reflected in higher turnover rates in vivo remains to be determined. During the trans-splicing reaction, the SL RNA is turned over as it is consumed in the reaction. SL RNA substrate levels might require tight regulation, since either excess or insufficient SL RNA substrate could be deleterious to the cells. Decapping of the SL RNA might be necessary under normal or particular conditions to maintain an appropriate level of the SL RNA substrate in cells. In addition, regulated turnover of the SL RNA substrate by Dcp2 could lead to global regulation of gene expression of trans-spliced genes. Nematode Dcp2 is active on the assembled SL RNP, since we previously demonstrated that SL RNAs assembled into snRNPs in cell extracts are substrates for Dcp2 decapping as well as 3Ј-to-5Ј decay (6) . Overall, our data suggest that Dcp2 proteins can efficiently decap TMG-capped RNAs and may be involved in the turnover of RNAs involved in several metabolic pathways. Dcp1/Dcp2 have been primarily localized by several groups in yeast and mammalian cells throughout the cytoplasm and in discrete cytoplasmic foci (P-bodies or processing bodies), although nuclear staining has also been observed (9, 22, 32, 33, 51, 53) . Dcp2 is primarily cytoplasmic and is present within discrete foci (both P-bodies and P-granules) in early embryos of C. elegans (S. Lall, F. Piano, and R. Davis, submitted for publication). C. elegans nuclear staining is not prominent, but it is detectable. Overall, these data suggest that Dcp2 is also present in the nuclei of cells and thus could participate in snand snoRNA turnover. Alternatively, as some snRNAs undergo maturation in the cytoplasm, Dcp2 could function on these RNAs during their cytoplasmic maturation.
Recently, a vertebrate U8 snoRNA binding protein with decapping activity was identified (19) . This decapping protein is primarily nucleolar in localization and decaps GpppG-, m 7 GpppG-, and m 2,2,7 GpppG-capped RNAs, generating primarily cap-derived diphosphate products in the presence of the Mn 2ϩ cation. Different decapping efficiencies were noted for different RNA substrates, including U8 snoRNA, U3 snoRNA, and 5S RNA. However, homologs of this protein are not readily identifiable outside of the vertebrate lineage. Thus, it seems likely that Dcp2 may be involved in the turnover of snand snoRNAs in nonvertebrate lineages.
Nematode Dcp1. Several lines of evidence indicate that Dcp2 is the primary catalytic subunit of the Dcp1/Dcp2 complex (31, 33, 53 ). We have not been able to detect any significant decapping activity using a variety of substrates (several VOL. 25, 2005 Dcp2 DECAPS m 2,2,7 GpppN-CAPPED RNAs 8789
RNAs containing different caps or free caps) and assay conditions (including Mn 2ϩ ) with either bacterially expressed or yeast-expressed C. elegans Dcp1. Using similar assay conditions, human Dcp1 is also inactive in vitro (33, 53) . More recently it has been suggested that in yeast Dcp1 is an enhancer of Dcp2 activity (7, 44, 47, 49) . Using several RNA substrates with different caps, we have not consistently observed significant enhancement of Dcp2 activity with Dcp1. Recently, overexpression of human Dcp1 in mammalian cells also was not found to significantly enhance decapping in vivo (34) . It remains to be determined whether posttranslational modifications, specific assay conditions, or auxiliary factors are required to enable Dcp1 to enhance Dcp2 in higher eukaryotes.
Expression of truncated forms of Dcp2. The C. elegans WormBase predicted two different RNAs and proteins that would lack the carboxy-terminal portion of the Nudix domain and Box B. We have identified RNAs by RT-PCR that would encode these proteins and have expressed and purified these proteins from bacteria. However, these proteins are catalytically inactive in our in vitro assays. What role these proteins might play or if they are catalytically active in vivo remains to be determined.
Conclusions. Nematode Dcp2 is an RNA-decapping enzyme that does not bind or function directly on caps but is effectively competed against by RNA. Our data suggest Dcp2 has at least two domains: the first binds to the substrate RNA, and the second is involved in catalysis of the decapping reaction. Notably, nematode Dcp2 decapping is influenced by both RNA sequence and context that appears independent of the initial RNA binding step. Finally, phylogenetically diverse Dcp2 proteins are capable of decapping TMG-capped RNAs and may therefore be involved in sn-and snoRNA turnover. Consequently, Dcp2 activity may influence several metabolic pathways.
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